Metformin is associated with improved survival in endometrial cancer (Q38165601)

30 August 2017

title

Metformin is associated with improved survival in endometrial cancer (English)

1 reference

30 August 2017

1 reference

7

Laura J Havrilesky

1 reference

30 August 2017

Angeles Alvarez Secord

series ordinal

8

object named as

Angeles Alvarez Secord

1 reference

30 August 2017

10

Paola A Gehrig

1 reference

30 August 2017

2

Paige Walter

1 reference

30 August 2017

3

Amanda Jackson

1 reference

30 August 2017

5

Jason Franasiak

1 reference

30 August 2017

6

Corey Bolac

1 reference

30 August 2017

11

Victoria Bae-Jump

1 reference

30 August 2017

Emily M Ko

1

1 reference

30 August 2017

Leslie Clark

series ordinal

4

1 reference

30 August 2017

Dominic T Moore

series ordinal

9

1 reference

30 August 2017

language of work or name

English

0 references

publication date

22 November 2013

1 reference

30 August 2017

1 reference

30 August 2017

volume

132

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

438-442

1 reference

Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Diabetes mellitus and risk of endometrial cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

The association between metabolic abnormality and endometrial cancer: a large case-control study in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Cardiovascular disease is the leading cause of death among endometrial cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Diabetes and cancer: a consensus report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Cellular and molecular mechanisms of metformin: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2 breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Metformin and the risk of cancer: time-related biases in observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Emerging therapeutic targets in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Promising novel therapies for the treatment of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2013.11.021

10.1016/J.YGYNO.2013.11.021

7 January 2021

Identifiers

DOI

1 reference

30 August 2017

1 reference